Skip to main content
Contact Us
Subscribe
E-Edition
63°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BIIB
Recent news which mentions BIIB
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
31
32
Next >
2 High-Yield Dividend Stocks That Are Trading Near Their 52-Week Lows
February 10, 2022
Tickers
AMGN
BIIB
GILD
MMM
Tags
AMGN
MMM
GILD
From
Motley Fool
2 Reasons to Buy Biogen, 1 Reason to Sell
February 10, 2022
Tickers
BIIB
Tags
BIIB
Recent Press Releases
Market News
From
Motley Fool
Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane
February 08, 2022
Tickers
BIIB
UCBJF
UCBJY
Tags
Benzinga
General
Briefs
From
Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
February 08, 2022
Tickers
ALKS
AMGN
AXSM
BIIB
Tags
Earnings
ALKS
INSP
From
Benzinga
10 Biggest Price Target Changes For Monday
February 07, 2022
Tickers
ANTM
APD
BIIB
DIS
Tags
DIS
RCL
EXPE
From
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Tickers
ABBV
ACLX
ALNY
AMGN
Tags
SNY
AZN
General
From
Benzinga
Biogen's Aduhelm Approval, Marketing Comes Under FTC, SEC Probes
February 04, 2022
Tickers
BIIB
Tags
General
Briefs
News
From
Benzinga
What 24 Analyst Ratings Have To Say About Biogen
February 04, 2022
Tickers
BIIB
Tags
Market News
BIIB
Benzinga
From
Benzinga
Analyst Ratings For Biogen
February 04, 2022
Tickers
BIIB
Tags
Market News
BIIB
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 4, 2022
February 04, 2022
Tickers
ARBE
BIIB
BJ
BZFD
Tags
BJ
BZFD
EL
From
Benzinga
10 Biggest Price Target Changes For Friday
February 04, 2022
Tickers
AMZN
BDX
BIIB
BILL
Tags
EL
PCTY
Benzinga
From
Benzinga
Biogen (BIIB) Q4 2021 Earnings Call Transcript
February 03, 2022
Tickers
BIIB
Tags
Market News
Recent Press Releases
BIIB
From
Motley Fool
Biogen's Alzheimer's Drug Clocks Q4 Sales Of Just $1M, FY22 Earnings Guidance Below Consensus
February 03, 2022
Tickers
BIIB
Tags
BIIB
Biotech
Market News
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 03, 2022
Tickers
ALPN
AMPS
ANIK
AXU
Tags
MMU
NVX
Options
From
Benzinga
Biogen: Q4 Earnings Insights
February 03, 2022
Tickers
BIIB
Tags
BZI/Recaps
BIIB
Market News
From
Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
Tickers
ABMD
ARWR
BIIB
BMY
Tags
PRDS
NVO
FDA
From
Benzinga
Recap: Biogen Q4 Earnings
February 03, 2022
Tickers
BIIB
Tags
Market News
BIIB
BZI/Recaps
From
Benzinga
Forecaster Yves Lamoureux has nailed several big market downturns. Here’s why he’s now turning bullish on stocks.
February 03, 2022
Tickers
AAPL
AMC
AMD
AMZN
Tags
XX:SXXP
QCOM
MRK
From
MarketWatch
Earnings Scheduled For February 3, 2022
February 03, 2022
Tickers
ABB
ABMD
AINV
ALCO
Tags
APTV
HSY
NOK
From
Benzinga
Earnings Preview For Biogen
February 02, 2022
Tickers
BIIB
Tags
BIIB
Earnings
Benzinga
From
Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
February 01, 2022
Tickers
BIIB
RHHBF
RHHBY
RHHVF
Tags
Non Hodgkin Lymphoma
BIIB
RHHBF
From
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
Tickers
ABBV
ABMD
AMLX
ARWR
Tags
FDA
General
SNY
From
Benzinga
Got $10,000? These 2 Growth Stocks Are Trading Near Their 5-Year Lows
January 29, 2022
Tickers
BABA
BIIB
FB
VTRS
Tags
Recent Press Releases
Market News
FB
From
Motley Fool
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
January 28, 2022
Tickers
ALXO
BGNE
BIIB
IBB
Tags
TARO
FDA
General
From
Benzinga
Biogen Sells Biosimilar-Venture Stake To Samsung Biologics For $2.3B
January 28, 2022
Tickers
BIIB
Tags
Market News
Biotech
BIIB
From
Benzinga
3 Stocks That Have Been Paying Dividends for a Combined 447 Years
January 28, 2022
Tickers
BIIB
LLY
SWK
TD
Tags
WFC
LLY
BIIB
From
Motley Fool
10 Biggest Price Target Changes For Monday
January 24, 2022
Tickers
BIIB
CHTR
CTSH
ECL
Tags
SLB
Price Target
Market News
From
Benzinga
Is Biogen a Buy?
January 22, 2022
Tickers
BIIB
LLY
Tags
LLY
BIIB
Market News
From
Motley Fool
3 Clinical Trials to Watch in the First Half of 2022
January 22, 2022
Tickers
ABBV
ARNA
BIIB
JPM
Tags
VRTX
ABBV
ARNA
From
Motley Fool
10 Biggest Price Target Changes For Tuesday
January 18, 2022
Tickers
AVB
BIIB
EAT
JBHT
Tags
Price Target Changes
Pre/Market Outlook
OVV
From
Benzinga
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.